• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1990 - 2021年中国及其各省因环境臭氧污染所致慢性阻塞性肺疾病负担:全球疾病负担研究2021的分析

Burden of chronic obstructive pulmonary disease attributable to ambient ozone pollution across China and its provinces, 1990-2021: An analysis for the Global Burden of Disease Study 2021.

作者信息

Jiang Yixuan, Yan Fanshu, Kan Haidong, Zhou Maigeng, Yin Peng, Chen Renjie

机构信息

School of Public Health, Key Lab of Public Health Safety of the Ministry of Education and NHC Key Lab of Health Technology Assessment, Fudan University, Shanghai 200032, China.

National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China.

出版信息

Chin Med J (Engl). 2024 Dec 20;137(24):3126-3135. doi: 10.1097/CM9.0000000000003415. Epub 2024 Dec 10.

DOI:10.1097/CM9.0000000000003415
PMID:39654451
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11706609/
Abstract

BACKGROUND

Epidemiological studies have demonstrated a causal relationship between ambient ozone (O 3 ) and mortality from chronic obstructive pulmonary disease (COPD), which is the only outcome considered in the Global Burden of Disease Study 2021 for O 3 . This study aims to evaluate the temporal trend and spatial distribution of the COPD burden attributable to O 3 across China from 1990 to 2021.

METHODS

The ambient O 3 concentrations in China were estimated. Based on the methodology framework and standard analytical methods applied in the Global Burden of Disease Study 2021, we estimated the annual number, age-standardized rate, and percentage of deaths and disability-adjusted life-years (DALYs) from COPD attributable to O 3 pollution during 1990-2021 at the national and provincial levels in China.

RESULTS

In 2021, a total of 125.7 (95% uncertainty interval [UI], 26.4-228.3) thousand deaths and 1917.5 (95% UI, 398.7-3504.6) thousand DALYs from COPD were attributable to ambient O 3 pollution in China, accounting for 9.8% (95% UI, 2.1-17.0%) and 8.1% (95% UI, 1.8-14.1%) of the total COPD deaths and DALYs, respectively. Generally, a higher burden was observed among males, the elderly, and the population residing in regions with worse health conditions. The age-standardized rates of COPD deaths and DALYs per 100,000 populations ranged from 0.5 (95% UI, 0-1.4) and 8.1 (95% UI, 0.7-20.9) in Hong Kong to 22.8 (95% UI, 3.9-43.5) and 396.6 (95% UI, 68.9-763.7) in Xizang. From 1990 to 2021, there was a notable decrease in the age-standardized rates of COPD-related deaths (68.2%, 95% UI, 60.1-74.9%) and DALYs (71.5%, 95% UI, 63.7-77.6%), especially in regions with poor health conditions. However, the attributable numbers and percentages changed relatively marginally.

CONCLUSIONS

Ambient O 3 pollution is a major contributor to the COPD burden in China. Our findings highlight the significant spatial heterogeneity across different provinces and underscore the implementation of geographically tailored policies to effectively reduce O 3 pollution and alleviate the associated disease burden.

摘要

背景

流行病学研究已证实环境臭氧(O₃)与慢性阻塞性肺疾病(COPD)死亡率之间存在因果关系,这是《2021年全球疾病负担研究》中针对O₃所考虑的唯一结果。本研究旨在评估1990年至2021年期间中国各地因O₃导致的慢性阻塞性肺疾病负担的时间趋势和空间分布。

方法

估算了中国的环境O₃浓度。基于《2021年全球疾病负担研究》应用的方法框架和标准分析方法,我们估算了1990 - 2021年期间中国全国和省级层面因O₃污染导致的慢性阻塞性肺疾病死亡人数、年龄标准化率、死亡百分比以及伤残调整生命年(DALYs)。

结果

2021年,中国因环境O₃污染导致的慢性阻塞性肺疾病死亡人数总计12.57(95%不确定区间[UI],2.64 - 22.83)万例,伤残调整生命年为191.75(95% UI,39.87 - 350.46)万例,分别占慢性阻塞性肺疾病总死亡人数和伤残调整生命年的9.8%(95% UI,2.1 - 17.0%)和8.1%(95% UI,1.8 - 14.1%)。总体而言,男性、老年人以及健康状况较差地区的人群负担更高。每10万人口中慢性阻塞性肺疾病死亡和伤残调整生命年的年龄标准化率在香港分别为0.5(95% UI,0 - 1.4)和8.1(95% UI,0.7 - 20.9),在西藏则为22.8(95% UI,3.9 - 43.5)和396.6(95% UI,68.9 - 763.7)。1990年至2021年期间,慢性阻塞性肺疾病相关死亡的年龄标准化率(68.2%,95% UI,60.1 - 74.9%)和伤残调整生命年(71.5%,95% UI,63.7 - 77.6%)显著下降,尤其是在健康状况较差的地区。然而,归因数量和百分比变化相对较小。

结论

环境O₃污染是中国慢性阻塞性肺疾病负担的主要促成因素。我们的研究结果凸显了不同省份之间显著的空间异质性,并强调实施因地制宜的政策以有效减少O₃污染并减轻相关疾病负担。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/531d/11706609/9fd8fd1bd7e1/cm9-137-3126-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/531d/11706609/e2c5767fa8b4/cm9-137-3126-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/531d/11706609/9fd8fd1bd7e1/cm9-137-3126-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/531d/11706609/e2c5767fa8b4/cm9-137-3126-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/531d/11706609/9fd8fd1bd7e1/cm9-137-3126-g002.jpg

相似文献

1
Burden of chronic obstructive pulmonary disease attributable to ambient ozone pollution across China and its provinces, 1990-2021: An analysis for the Global Burden of Disease Study 2021.1990 - 2021年中国及其各省因环境臭氧污染所致慢性阻塞性肺疾病负担:全球疾病负担研究2021的分析
Chin Med J (Engl). 2024 Dec 20;137(24):3126-3135. doi: 10.1097/CM9.0000000000003415. Epub 2024 Dec 10.
2
[Burden of chronic obstructive pulmonary disease attributable to ambient ozone pollution in 1990 and 2013 in China].[1990年和2013年中国环境臭氧污染所致慢性阻塞性肺疾病负担]
Zhonghua Yu Fang Yi Xue Za Zhi. 2016 May;50(5):391-6. doi: 10.3760/cma.j.issn.0253-9624.2016.05.002.
3
National and provincial burden of disease attributable to fine particulate matter air pollution in China, 1990-2021: an analysis of data from the Global Burden of Disease Study 2021.1990 - 2021年中国因细颗粒物空气污染导致的国家和省级疾病负担:基于2021年全球疾病负担研究数据的分析
Lancet Planet Health. 2025 Mar;9(3):e174-e185. doi: 10.1016/S2542-5196(25)00024-5.
4
The effect of air pollution on deaths, disease burden, and life expectancy across China and its provinces, 1990-2017: an analysis for the Global Burden of Disease Study 2017.空气污染对中国及其省份 1990-2017 年死亡、疾病负担和预期寿命的影响:2017 年全球疾病负担研究分析。
Lancet Planet Health. 2020 Sep;4(9):e386-e398. doi: 10.1016/S2542-5196(20)30161-3. Epub 2020 Aug 17.
5
Global burden of chronic obstructive pulmonary disease attributable to ambient ozone in 204 countries and territories during 1990-2019.1990 - 2019年期间204个国家和地区因环境臭氧导致的慢性阻塞性肺疾病全球负担
Environ Sci Pollut Res Int. 2022 Feb;29(6):9293-9305. doi: 10.1007/s11356-021-16233-y. Epub 2021 Sep 9.
6
Diseases Burden of Chronic Obstructive Pulmonary Disease (COPD) Attributable to Ground-Level Ozone in Thailand: Estimates Based on Surface Monitoring Measurements Data.泰国地面臭氧导致的慢性阻塞性肺疾病(COPD)疾病负担:基于地面监测测量数据的估计
Glob J Health Sci. 2015 May 14;8(1):1-13. doi: 10.5539/gjhs.v8n1p1.
7
Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.全球、地区和国家慢性阻塞性肺疾病和哮喘的死亡、患病率、残疾调整生命年以及与残疾相关的生命年,1990-2015 年:2015 年全球疾病负担研究的系统分析。
Lancet Respir Med. 2017 Sep;5(9):691-706. doi: 10.1016/S2213-2600(17)30293-X. Epub 2017 Aug 16.
8
Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.1990-2017 年慢性呼吸道疾病的流行情况和可归因健康负担:2017 年全球疾病负担研究的系统分析。
Lancet Respir Med. 2020 Jun;8(6):585-596. doi: 10.1016/S2213-2600(20)30105-3.
9
The Burden of COPD in China and Its Provinces: Findings From the Global Burden of Disease Study 2019.中国及各省 COPD 负担:来自 2019 年全球疾病负担研究的发现。
Front Public Health. 2022 Jun 3;10:859499. doi: 10.3389/fpubh.2022.859499. eCollection 2022.
10
Burden of non-communicable diseases in China and its provinces, 1990-2021: Results from the Global Burden of Disease Study 2021.中国及其省份的非传染性疾病负担,1990-2021 年:2021 年全球疾病负担研究结果。
Chin Med J (Engl). 2024 Oct 5;137(19):2325-2333. doi: 10.1097/CM9.0000000000003270. Epub 2024 Aug 28.

引用本文的文献

1
The Inhibitory Effects of ARA301 Extract on Lipopolysaccharide-Induced Lung Injury .ARA301提取物对脂多糖诱导的肺损伤的抑制作用
J Microbiol Biotechnol. 2025 Mar 6;35:e2412043. doi: 10.4014/jmb.2412.12043.

本文引用的文献

1
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球疾病负担研究 2021 年在 204 个国家和地区、811 个次国家级地点对 88 种风险因素的全球负担和证据强度:系统分析。
Lancet. 2024 May 18;403(10440):2162-2203. doi: 10.1016/S0140-6736(24)00933-4.
2
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球 204 个国家和地区及 811 个亚级行政区 1990 年至 2021 年 288 种死因及预期寿命的归因分析:全球疾病负担研究 2021 系统分析。
Lancet. 2024 May 18;403(10440):2100-2132. doi: 10.1016/S0140-6736(24)00367-2. Epub 2024 Apr 3.
3
Association between long-term ozone exposure and readmission for chronic obstructive pulmonary disease exacerbation.长期臭氧暴露与慢性阻塞性肺疾病恶化再入院的关系。
Environ Pollut. 2024 May 1;348:123811. doi: 10.1016/j.envpol.2024.123811. Epub 2024 Mar 24.
4
Combined effect of ozone and household air pollution on COPD in people aged less than 50 years old.臭氧和家庭空气污染对 50 岁以下人群 COPD 的联合影响。
Thorax. 2023 Dec 15;79(1):35-42. doi: 10.1136/thorax-2022-219691.
5
Drivers of Increasing Ozone during the Two Phases of Clean Air Actions in China 2013-2020.2013-2020 年中国两阶段清洁空气行动期间臭氧增加的驱动因素。
Environ Sci Technol. 2023 Jun 20;57(24):8954-8964. doi: 10.1021/acs.est.3c00054. Epub 2023 Jun 5.
6
Long-term ambient air pollution exposure and cardio-respiratory disease in China: findings from a prospective cohort study.长期暴露于环境空气中的污染物与中国的心肺疾病:一项前瞻性队列研究的结果。
Environ Health. 2023 Mar 27;22(1):30. doi: 10.1186/s12940-023-00978-9.
7
Improved air quality and reduced burden of preterm birth in China: 2013-2017.中国2013 - 2017年空气质量改善与早产负担减轻
Sci Bull (Beijing). 2022 May 15;67(9):879-882. doi: 10.1016/j.scib.2022.01.022. Epub 2022 Jan 31.
8
Synergic emissions reduction effect of China's "Air Pollution Prevention and Control Action Plan": Benefits and efficiency.中国“大气污染防治行动计划”的协同减排效应:效益与效率。
Sci Total Environ. 2022 Nov 15;847:157564. doi: 10.1016/j.scitotenv.2022.157564. Epub 2022 Jul 28.
9
Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年慢性阻塞性肺疾病负担及其可归因危险因素:2019 年全球疾病负担研究结果。
BMJ. 2022 Jul 27;378:e069679. doi: 10.1136/bmj-2021-069679.
10
The Burden of COPD in China and Its Provinces: Findings From the Global Burden of Disease Study 2019.中国及各省 COPD 负担:来自 2019 年全球疾病负担研究的发现。
Front Public Health. 2022 Jun 3;10:859499. doi: 10.3389/fpubh.2022.859499. eCollection 2022.